Oxidative stress is a feature of cholestatic syndrome and induces multidrug resistance-associated protein 2 (Mrp2) internalization from the canalicular membrane surface. We have previously shown that the activation of a novel protein kinase C (nPKC) by oxidative stress regulates Mrp2 internalization. The internalized Mrp2 was recycled to the canalicular surface in a protein kinase A (PKA)-dependent manner after intracellular glutathione (GSH) levels were replenished. However, the putative phosphorylation targets of these protein kinases involved in reversible Mrp2 trafficking remain unclear. In this study, we investigated the effect of changing the intrahepatic redox status on the C-terminal phosphorylation status of radixin (p-radixin), which links Mrp2 to F-actin, and the interaction of p-radixin with Mrp2 in rat hepatocytes. We detected a significant decrease in the amount of p-radixin that co-immunoprecipitated with Mrp2 after tertiary-butylhydroperoxide (t-BHP) treatment. After treatment with GSH-ethylester (GSH-EE), the phosphorylation level became the same as that of the control. A PKC and protein phosphatase (PP)-1/2A inhibitor, but not a PP-2A selective inhibitor, prevented the t-BHP-induced decrease of p-radixin and subsequent canalicular Mrp2 localization. In contrast, a PKA inhibitor affected the recovery process facilitated by GSH-EE treatment. In conclusion, the interaction of p-radixin with Mrp2 was decreased by the activation of PKC and PP-1 under oxidative stress conditions which subsequently led to Mrp2 internalization, whereas the interaction of p-radixin and Mrp2 was increased by the activation of PKA during recovery from oxidative stress.
Introduction
Multidrug resistance-associated protein 2 (MRP2/ABCC2) and bile-salt export pump (BSEP/ABCB11) are involved in the formation of bile-salt-independent and -dependent bile flow, respectively. MRP2 is expressed statically on the canalicular surface, but MRP2 dynamic insertion and internalization processes are also of great importance because the steady-state expression level of MRP2 is directly dependent on its turnover rate. It is suggested that the disruption of these turnover rates leads to cholestatic jaundice. Disrupted canalicular localization of MRP2 has been observed in patients with chronic cholestatic disorder and hepatic failure, i.e., primary biliary cirrhosis (PBC) and hepatitis C virus infection) [1] . Oxidative stress markers were also closely correlated in these chronic liver failure patients [2] . These observations strongly suggest that both the mRNA expression of canalicular transporters, and their localization are of equal importance in human liver failure. We have previously demonstrated that Mrp2 internalization is observed when acute oxidative stress is induced in rat livers using ethacrynic acid-, tert-butylhydroperoxide (t-BHP) and lipopolysaccharide (LPS) [3] [4] [5] [6] . We have also shown that Mrp2 localization returns to the canalicular membrane after the replenishment of intracellular GSH [5] . Microtubule polymerization and protein kinase A (PKA) are essential factors in the Mrp2 sorting process, which suggests that the balance between PKC activation and PKA activation is a key regulator of reversible Mrp2 trafficking. The molecular phosphorylation targets of protein kinases that reversibly regulate canalicular Mrp2 localization remain unclear.
The ezrin/radixin/moesin (ERM) protein family link cytoskeletal actin filaments (F-actin) and integral membrane proteins. The anchoring function of ERM proteins is regulated by the C-terminal phosphorylation status of these proteins, via the transition between active (C-terminal phosphorylated) and inactive (C-terminal dephosphorylated) forms [7] . Radixin is the dominant ERM protein in the canalicular membrane of the liver. Mice lacking radixin develop conjugated hyperbilirubinemia because of their impaired ability to localize Mrp2 to the canalicular membrane surface, which suggests that radixin is required for the canalicular localization of Mrp2 [8] . Disturbed co-localization of Mrp2/MRP2 and radixin, as well as endocytic retrieval of MRP2, was observed in the liver of PBC patients and in several experimental cholestatic models, which suggests that there may be an association with a failure in the anchoring of Mrp2/MRP2 to the canalicular membrane [1, 9] . We showed that conventional PKC (cPKC) activation decreases the amount of the active form (C-terminal phosphorylated form) of ezrin which reduces the protein-protein interaction between ezrin and Mrp2 in the rat small intestine [10] . LPS induced a change in the C-terminal phosphorylation status of radixin, which led to its dissociation from Mrp2 and subsequent internalization in rat liver [11] . Although it has been reported that the C-terminal phosphorylation status of radixin regulates the canalicular Mrp2 localization [12] , the redox sensitive activation of protein kinases or phosphatases that are directly involved in the dephosphorylation of the C-terminus threonine (Thr564) of radixin have not been elucidated. In this study, we tested the hypothesis that radixin is the phosphorylation target of redox-sensitive protein kinases that regulate reversible Mrp2 localization. We tested this hypothesis using an in situ rat liver perfusion study and isolated rat hepatocyte couplets (IRHCs). Our results indicate that the interaction of C-terminally (Thr564) phosphorylated radixin (p-radixin) with Mrp2 was decreased by the activation of protein phosphatase 1 triggered by the PKC activation under oxidative stress conditions. This subsequently led to Mrp2 internalization, whereas the interaction between p-radixin and Mrp2 was increased by the activation of PKA during the recovery process from oxidative stress. The balance of the activation between PKA and PKC was accompanied by the variations in intercellular GSH content, which were determined by the phosphorylation status of radixin. A change in the phosphorylation status of radixin reversibly regulates the protein interaction between the p-radixin and Mrp2, and the redoxsensitive canalicular localization of Mrp2.
Materials and methods

Chemicals and antibodies
t-BHP and glutathione-reduced ethyl ester (GSH-EE) were obtained from Sigma-Aldrich Chemicals (St. Louis, MO). Gö6850 and protein kinase A inhibitor 14-22 amide, cell-permeable myristoylated, were from Calbiochem (Darmstadt, Germany). Rabbit anti-Mrp2 polyclonal antibody (EAG15) was raised against the 12-amino acid sequence at the carboxyl terminus of rat Mrp2, as previously described by Keppler [13] . Rabbit anti-phosphorylated ezrin (Thr567)/radixin (Thr564)/moesin (Thr558) (p-ERM) antibody was purchased from Millipore (Temecula, CA). Rat anti-radixin (R21) was kindly provided by Dr. Sachiko Tsukita (Osaka University, Japan). The horseradish peroxidase-linked secondary antibodies used in the immunoblot analysis were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). All chemicals and solvents were of analytical grade.
Animals
Male Sprague-Dawley rats (SDR) weighing 170-220 g (six to seven weeks old) obtained from Japan SLC Inc. (Shizuoka, Japan) were used in the study. The animals were treated humanely in accordance with the guidelines issued by the National Institutes of Health and all protocols were approved by the animal care and use committee of Chiba University.
Rat liver perfusion
Rat livers were perfused in situ in a non-recirculating system with Krebs-Henseleit bicarbonate buffer (120 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl 2 , 5 mM glucose, pH 7.4, at 37°C), as previously described [3] . Rat livers were perfused with or without 500 μM t-BHP for 30 min and subsequently perfused for 1 h with 3 mM GSH-EE (cell permeable form of GSH). Liver samples weighing 2 g were snap-frozen in liquid nitrogen.
IRHC preparation
Hepatocytes were isolated from SDR liver using limited collagenase digestion, as previously described [14] . After isolation, rat hepatocytes were maintained (5 × 10 5 cells/mL) prior to seeding at 4°C in Williams' medium E supplemented with 10% fetal bovine serum, penicillin (100,000 units/mL) and streptomycin (100 μg/mL). Cell viability was assessed by trypan blue exclusion and remained greater than 92%.
Cell processing
Cell processing was performed as previously described, but with the following modifications [3, 4, 15] . Hepatocytes were plated at a density of 2.5 × 10 6 cells per 60 mm culture plate and maintained at 37°C for 3 h in a CO 2 incubator. Cells were added to 100 μM t-BHP and incubated for 10 min. The medium was subsequently replaced with 3 mM GSH-EE for 30 min. In inhibition experiments, cells were pretreated with inhibitors for 30 min prior to exposure to t-BHP. After the treatments, cells were scraped into ice-cold buffer A (20 mM Tris, 250 mM sucrose, 5 mM EGTA, 1 mM MgCl 2 ) supplemented with 1 mM phenylmethylsulfonyl fluoride, and a 0.1% protease inhibitor cocktail, before immediate sonication using a Taitec VP-5S (Saitama, Japan).
Measurement of intracellular GSH content
Samples were mixed with 3-fluorotyrosine as an internal standard, followed by filtration through a 0.45-μm Millex-LH syringe filter from Millipore (Bedford, MA). HPLC was performed as described previously [16] . Chromatographic separation was achieved using an Inertsil ODS column (4.6 mm internal diameter × 250 mm; GL Sciences Ltd., Tokyo, Japan) with 0.1% trifluoroacetic acid:methanol (20:1) as the mobile phase at a flow rate of 1.0 mL/min. Eluate from the column was mixed with a solution containing 18.6 mM o-phthalaldehyde and 17.1 mM 2mercaptoethanol in 100 mM carbonate buffer (pH 10.5), delivered at a rate of 0.2 mL/min. The mixture was then passed through a stainless steel coil at 70°C to facilitate derivatization. A fluorescence detector at an excitation wavelength of 355 nm and an emission wavelength of 425 nm was used. The reduced GSH concentration was calculated with reference to the height of the standard reduced GSH sample.
Western blot analysis
The homogenate (20 μg protein for radixin and 45 μg protein for pradixin) prepared from treated rat hepatocytes was separated using 8.5% polyacrylamide slab gel containing 0.1% SDS before electrophoretic transfer to an Immobilon-P transfer membrane filter (Millipore Corporation, Billerica, MA). The membrane was blocked overnight at 4°C using TTBS (Tris-buffered saline with 0.05% Tween 20) containing 3% bovine serum albumin (BSA), before being probed at room temperature for 1 h with primary antibodies diluted with TTBS containing 0.1% BSA. The membrane was incubated for 1 h at room temperature with secondary antibodies conjugated with horseradish peroxidase and diluted with TTBS containing 0.1% BSA. The membrane was visualized with ChemiDoc (Bio-Rad Laboratories Inc., CA.) using an enhanced chemiluminescence system (GE Healthcare, Little Chalfont, UK).
Immunofluorescence analysis
Small frozen blocks of liver were embedded in Tissue-Tek O.C.T. compound (Sakura Finetechnical Co. Ltd., Tokyo, Japan) and cut into 5-μm thick sections at −25°C, before acetone fixation at room temperature for 10 min. Sections were hydrated on slides for 15 min in 30 mM glycine-containing phosphate-buffered saline (G-PBS). In certain experiments, isolated hepatocytes were plated on glass cover slips at a density of 2.0 × 10 5 cells/mL/12-wells and incubated in a CO 2 incubator for 3 h to form IRHCs. These were then further incubated for 10 min with or without 100 μM t-BHP. In other experiments, cells were pretreated with inhibitors for 30 min, prior to exposure to t-BHP. IRHCs were fixed with 4% formaldehyde/PBS for 15 min and permeabilized in 0.1% Triton X-100/PBS for 10 min. After fixation, the rat liver sections and IRHCs were probed with anti-Mrp2 antiserum (1:50) and antibodies to the active form of radixin (p-ERM) (1:25) for 1 h. Samples were washed with PBS and incubated for 1 h with FITC and/or Alexa 546-conjugated secondary antibodies (1:250). Antibodies were diluted in PBS containing 1% bovine serum albumin. IRHC samples were treated with 0.2 mg/mL RNase A in PBS for 20 min at room temperature, prior to mounting on a Vectashield (Vector Laboratories, Burlingame, CA.) containing propidium iodide to reduce background fluorescence. Cells and liver sections were blind analyzed using a Carl Zeiss LSM510 confocal laser scanning microscope (Jena, Germany). We randomly chose ten fields per cover slip and counted the nuclei (30 to 50 nuclei per field) and Mrp2. The ratios Mrp2-positive pseudocanaliculi per cell nucleus was calculated to define the Mrp2-index and processed for statistical analysis.
Immunoprecipitation analysis
Treated IRHCs were lysed for 1 h at 4°C with lysis buffer (25 μl/mg protein) containing 25 mM Tris/HCl, pH 7.5, 5 mM EDTA, 250 mM NaCl, 1% (v/v) Triton X-100, 60 mM n-octyl-β-D-glucopyranosid, 50 mM NaF, 1 mM Na 3 VO 4 , and protease inhibitor (1 mM PMSF, 5 μg/mL leupeptin, and 1 μg/mL pepstatin A). The tissue homogenate was centrifuged at 20,630 g for 10 min. The supernatant was collected as tissue lysate and rotated overnight at 4°C with protein G and anti-Mrp2 antibody. The beads were centrifuged at 9170 g for 1 min and washed three times with a wash buffer containing 25 mM Tris/HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% (v/v) Triton X-100, 50 mM NaF, and 1 mM Na 3 VO 4 . Finally an elution buffer containing 10 mM Tris/HCl, pH 6.5, 3% (w/v) SDS, 10% (v/v) glycerol, 5% (v/v) βmercaptoethanol, 8 M urea, and 0.001% bromophenol blue was added, before heating at 95°C for 5 min. The suspension was centrifuged, and the supernatant was analyzed by SDS-polyacrylamide gel electrophoresis, followed by immunoblot analysis.
Statistical analysis
Data were calculated as mean ± S.D. We analyzed data statistically using Bonferroni correction. We considered differences in means to be significant at the p b 0.05 level.
Results
Mrp2 localization was reversibly regulated by the intracellular redox status in IRHCs
t-BHP is known to be highly extracted by the liver in a single perfusion [17] and catalyzed by glutathione peroxidase [18] , while GSH-EE is known as a cell-permeable form of GSH that undergoes hydrolysis by intracellular esterases, thereby increasing the intracellular GSH level rapidly. The IRHC is an established experimental system that maintains apical-basal polarity and endogenous liver-specific protein expression Table 1 Mrp2 localization is reversibly regulated by the intracellular redox status in IRHCs. IRHCs were treated with/without 100 μM t-BHP for 10 min, and then treated with/without 3 mM GSH-EE for 30 min. Both the intracellular GSH content and Mrp2-index decreased to approximately half that of the control treatment after exposure to 100 μM t-BHP but recovered to match the control value after treatment with 3 mM GSH-EE for 30 on the canalicular membrane. Mrp2 was generally localized to the canalicular space between adjacent hepatocytes couplets but was reorganized after isolation for approximately 3 h. We calculated the ratio of Mrp2-positive pseudocanaliculi per cell nucleus to define the Mrp2-index, as previously described [4] . We confirmed the relationship between intracellular GSH level and the Mrp2-index in IRHCs, as reported in the in situ liver perfusion study (Table 1 ; [5] ). The intracellular GSH decreased to about half of the control after exposure to 100 μM t-BHP for 10 min. Intracellular GSH was completely restored by subsequent treatment with 3 mM GSH-EE for 30 min (Table 1) . Likewise, the Mrp2-index was decreased and restored by t-BHP and subsequent GSH-EE treatment, respectively (Table 1) .
Effect of t-BHP and GSH-EE perfusion on the intracellular GSH content and canalicular Mrp2 and p-radixin localization in perfused rat livers
As previously reported, 500 μM t-BHP perfusion led to a decrease of the hepatic reduced form of GSH by more than half of control within 30 min after perfusion [19] . In addition, hepatic GSH content remained low after subsequent KHB buffer perfusion for 60 min. On the other hand, subsequent 3 mM GSH-EE perfusion for 60 min replenished the hepatic GSH content almost completely (91.1 ± 4.6% of control) (Fig. 1A) . Previous studies reported that 3 h treatment with LPS led to changes in the localization of Mrp2 and radixin from the canalicular membrane [11] . We then investigated whether the modified canalicular localization of p-radixin induced by t-BHP and GSH-EE was accompanied by changes in the intracellular GSH concentration. Immunofluorescence analysis showed the colocalization of Mrp2 and p-radixin in rat liver controls. Mrp2 and radixin staining was reduced in liver perfused with t-BHP (500 μM for 30 min), and co-localization was partially disrupted (Fig. 1B) . In contrast, Mrp2 and p-radixin co-localization in the canalicular surface was restored by GSH-EE (3 mM) perfusion for 30 min, which induced the replenishment of intracellular GSH (Fig. 1B) . Our data suggest that radixin phosphorylation status might regulate reversible Mrp2 localization, which is accompanied by a change in the intracellular redox status. Effect of protein kinase inhibitors on changes in radixin expression (B), p-radixin expression (C) and Mrp2-index in IRHCs, which were induced by t-BHP and/or GSH-EE. IRHCs were pretreated with/without protein kinase inhibitors for 30 min, and the cells were subsequently treated with t-BHP and GSH-EE. Total radixin expression (B), active form of radixin (p-radixin; C) and Mrp2-index were analyzed following the treatments. Both decreased p-radixin expression and Mrp2-index induced by the t-BHP exposure were suppressed by the pretreatment with Gö6850 (PKC inhibitor). In contrast, the recovery of p-radixin expression and Mrp2-index induced by the GSH-EE was suppressed by the pretreatment with a PKA inhibitor. Results are shown as the mean ± S.D. for four independent IRHCs isolations. *p b 0.05, **p b 0.01, significantly different from control. # p b 0.01, significantly different from t-BHP 100 μM.
Effect of protein kinase inhibitors on changes in the C-terminal phosphorylation status of radixin and Mrp2 localization in IRHCs induced by t-BHP and/or GSH-EE
We previously reported that the dephosphorylation of C-terminal phosphorylated radixin occurs without a change in the total radixin expression (both activated and inactivated forms) after a 3 h treatment with LPS [11] . Previous reports also indicated that conventional PKC (cPKC) activation decreases the amount of the active form (C-terminally phosphorylated) of ezrin, which diminishes the protein-protein interaction between ezrin and Mrp2 in the rat small intestine [10] . We investigated the effect of GSH-EE and protein kinase inhibitors on the dephosphorylation of C-terminally phosphorylated radixin in acute oxidative stress conditions induced by t-BHP. Total radixin expression in the t-BHP-treated homogenate (phosphorylated and dephosphorylated forms) was comparable to that observed with other treatments (106.6 ± 7.8%; Fig. 2B ). In addition, the p-radixin content of the t-BHP-treated homogenate was significantly reduced compared to the control (75.3 ± 8.8%). Subsequent GSH-EE treatment restored the t-BHP-induced decrease of p-radixin to control levels (103.3 ± 12.3%; Fig. 2C ). Pretreatment with Gö6850 (PKC inhibitor) suppressed the t-BHP-induced decrease of p-radixin to control levels (121.1 ± 11.5%; Fig. 2C ). In contrast, the recovery of p-radixin after GSH replenishment was significantly inhibited in the presence of a PKA inhibitor (43.9 ± 9.0%), thereby affecting the decrease of p-radixin expression induced by t-BHP exposure (42.1 ± 9.7%; Fig. 2C ). We confirmed that the PKC inhibitor prevented the t-BHP induced decrease of Mrp2-index, but it did not affect its recovery process by GSH-EE treatment. However, the, PKA inhibitor did not affect the t-BHP induced decrease of Mrp2-index, but affected its recovery by GSH-EE treatment (Fig. 2D ). Our data suggest that C-terminally phosphorylated radixin is converted to its dephosphorylated form by t-BHP treatment. The dephosphorylated form of radixin was restored when the intracellular GSH content was replenished. Phosphorylation status is strictly regulated by the activation of PKC (dephosphorylation of p-radixin) and PKA (phosphorylation of radixin).
Effect of protein kinase inhibitors on changes in Mrp2-p-radixin interaction in IRHCs induced by t-BHP and/or GSH-EE
We investigated the molecular interaction of Mrp2 with p-radixin using immunoprecipitation analysis to obtain insight into the molecular mechanism involved in reversible Mrp2 localization, which is accompanied by changes in the intracellular redox status. P-radixin was readily co-immunoprecipitated with Mrp2 in the control cell lysate, as described previously [8] . The interaction between Mrp2 and radixin was not detected when pre-immune rabbit IgG was used in the immunoprecipitation experiment (data not shown). The amount of Mrp2 immunoprecipitated with anti-Mrp2 antibody was unchanged in all treatments, whereas the amount of p-radixin in the immunoprecipitate was decreased by t-BHP treatment (31.4 ± 10.5%; Fig. 3 ). In contrast, the t-BHP-induced decrease in the Mrp2-p-radixin interaction was restored by replenishment of intrahepatic GSH content. Pretreatment with Gö6850 suppressed the t-BHP-induced decrease in the Mrp2-p-radixin interaction down to control levels (124.5 ± 9.6%; Fig. 3 ). Recovery of the dephosphorylated p-radixin after GSH replenishment was significantly inhibited in the presence of a PKA inhibitor (42.1 ± 5.4%; Fig. 3 ). Our results suggest that the C-terminally phosphorylation status of radixin is an important factor in the reversible interaction of Mrp2 with p-radixin, and that the balance in PKC/PKA activation is triggered by the intracellular redox status.
Effect of protein phosphatase inhibitors on the t-BHP-induced change in expression of radixin (A) and p-radixin (B) in IRHCs
Multiple kinases [20] and putative protein phosphatase(s) [21] are involved in the phosphorylation and dephosphorylation of the C- terminal threonine of ERM proteins (Ezrin: Thr567, Radixin: Thr564, Moesin: Thr558), which regulate the balance between active and inactive forms. However, the protein kinase(s) or phosphatase(s) that are directly involved in the modification of radixin by dephosphorylating its C-terminus threonine (Thr564) have not been elucidated. We investigated the effect of serine/threonine phosphatase isoform inhibitors on the dephosphorylation of C-terminally phosphorylated radixin in acute oxidative stress conditions induced by t-BHP (Fig. 4A) . Our results show that total radixin expression was comparable with that observed in all treatments (Fig. 4B) . The pretreatment with the protein phosphatase (PP)-1 and -2A inhibitor, 1 μM okadaic acid (OA), for 30 min significantly increased p-radixin compared to the control value (129.4± 8.5%) and suppressed the t-BHP-induced decrease in p-radixin to the same extent (123.3± 10.3%; Fig. 4C ). In contrast, the PP-2A selective inhibitor endothall (ET; 1 μM for 30 min) affected neither the t-BHP-induced decrease in p-radixin content (63.2 ± 8.5%) nor the basal expression of p-radixin (104.2 ± 10.7%; Fig. 4C ). Inhibitor concentrations were set so as to selectively inhibit target molecules according to the product instructions, or previous reports [22, 23] . Our data suggest that the t-BHP-induced decrease of Thr564-phosphorylated radixin was regulated by the activation of PP-1. PP-1 activation was also involved in the constitutive dephosphorylation of p-radixin under normal conditions.
Effect of protein phosphatase inhibitors on the t-BHP-induced internalization of Mrp2 in IRHCs
We investigated whether the inhibition of protein phosphatase-1 and/or -2A could inhibit t-BHP-induced Mrp2 internalization in IRHCs. Our results confirmed the effect on p-radixin. Pretreatment with the PP-1 and -2A inhibitor OA (1 μM for 30 min) significantly increased the Mrp2-index compared to the control value (14.5 ± 1.4%), and suppressed the t-BHP-induced decrease of p-radixin content to the same extent. In contrast, the PP-2A selective inhibitor ET (1 μM for 30 min) did not affect the t-BHP-induced decrease in the Mrp2-index (3.8 ± 0.8%; Fig. 4D ). Our data suggest that t-BHP-induced PP-1 activation is involved in Mrp2 internalization, accompanied by the Thr564 dephosphorylation of radixin.
Discussion
In the liver, Mrp2 is thought to be stably expressed in the apical membrane by binding to radixin through the postsynaptic density-95/discs large/zona occludens-1 (PDZ) proteins, i.e., Na + /H + exchanger regulatory factor 1 (NHERF1) and PDZ domain-containing protein 1 [8, [22] [23] [24] . Dephosphorylated radixin adopts an inactive conformation via intramolecular/intermolecular interactions between its N-terminal and C-terminal domains. The inactive form of radixin loses its ability to bind membrane proteins and the cytoskeleton because its N and C termini are masked. It was reported that Cterminally dephosphorylated mutant ezrin (T567A) is distributed diffusely in the cytoplasm, whereas phosphorylated mutant ezrin (T567D) is distinctly localized to the membrane surface. This indicates that the membrane localization of radixin is strictly dependent on its C-terminal phosphorylation status [25] . In several studies using the rat cholestatic model, phosphorylated radixin localization was not observed beneath the canalicular lumen [11, 26] . Our data also suggest that the p-radixin is not retained near the canalicular surface space, as shown in Fig. 1B . Co-localization of Mrp2 and p-radixin in the canalicular space was restored by replenishment of the GSH content without changing total radixin expression ( Figs. 1 and 2 ). This suggests that dephosphorylated radixin was internalized into the cytosolic compartment and relocated to the canalicular surface in tandem with Thr564 phosphorylation.
Multiple kinases, which include Rho small GTPase, [27] [28] [29] and putative protein phosphatases [21] are involved in the phosphorylation and dephosphorylation of the C-terminal threonine residue of ERM proteins. In this study, we have shown that t-BHP induces the dephosphorylation of p-radixin which subsequently results in the dissociation of Mrp2 from radixin, ultimately leading to Mrp2 internalization. In contrast, p-radixin was phosphorylated after GSH-EE treatment in a PKA-dependent manner and the association between Mrp2 and p-radixin was restored. These are schematically represented in Fig. 5 . In previous reports, it was demonstrated that a cell-permeable cAMP analog, dibutyryl cAMP, stimulates bile flow in the perfused rat liver [30] and sorting of Mrp2 from cytosol to the apical membrane in IRHCs [31] . Our previous reports also stressed the importance of the cAMP-PKA signaling pathway, where recovery of the Mrp2-index after GSH replenishment was significantly inhibited in the presence of a PKA inhibitor [5] . ERM proteins and PDZ proteins associate with PKA [32] , which suggests a possible involvement of cAMP-PKA signaling in the exocytic insertion of Mrp2 at the canalicular surface. We found that the reduction in p-radixin and its interaction with Mrp2 were completely restored with the replenishment of intrahepatic GSH. These effects were significantly inhibited by pretreatment with a PKA inhibitor ( Figs. 2 and 3 ). From these observations, it can be concluded that the activity balance of PKC and PKA, which depends on GSH content, regulates the phosphorylation status of p-radixin. This subsequently modulates the interaction of pradixin with Mrp2, and finally leads to Mrp2 localization in a reversible manner.
We have shown that decreases in p-radixin and the Mrp2-index, which were induced by t-BHP treatment, could be prevented by nonspecific inhibitors of PP-1 and PP-2A (OA 1 μM; IC 50 ; PP-1: 10-15 nM, PP-2A: 0.1 nM), but not by a PP-2A selective inhibitor (ET 1 μM; IC 50 ; PP-1: 5 μM, PP-2A: 90 nM). Our preliminary studies confirmed the molecular interactions of the catalytic subunit isotype (phosphoprotein phosphatase-1 catalytic subunit α: PPP-1Cα) with C-terminal cytosolic region of Mrp2, indicating the substrate specificity of PP-1 for both Mrp2 and radixin. Our data suggest that PP-1 is involved in t-BHP-induced Mrp2 internalization resulting from the dephosphorylation of Thr564 in radixin. Using our experimental conditions, it is unclear whether PP-1 is actually activated following PKC though a previous report showed that PP-1 (but not PP-2A) activity was selectively down-regulated in PKCα-deficient mice [33] . PP-1 activity is suppressed in cardiac myocytes by protein phosphatase inhibitor-1 (PPI-1), but PKCα-dependent phosphorylation of PPI-1 at Ser67 leads to the dissociation of PPI-1 from PP-1, resulting in PP-1 activation.
PKA-dependent phosphorylation of PPI-1 at Thr35 results in the association of PPI-1 with PP-1, which finally leads to its inactivation [34] . These observations suggest that PP-1 activity is modulated by the phosphorylation of PPI-1, which is in turn mediated by the balance of PKC and PKA activation. Although, we did not determine whether the phosphorylation status of PPI-1 was altered by the intracellular redox status in IRHCs, this is a possible mechanism for PKC-mediated PP-1 activation.
Oxidative stress markers, including the increase of major lipid peroxidation (malondialdehyde and 4-hydroxynonenal) metabolites and those indicating a decline in the anti-oxidant status (total GSH and vitamin A and C), closely correlate with the progression of chronic cholestatic disorder in patients with chronic hepatic failure (PBC and hepatitis C virus infection) [2, 35] . In these patients, the disruption of the canalicular localization of MRP2, in the absence of changes in expression levels, is probably caused by a shortage of radixin around the canalicular region, as demonstrated in the liver of PBC patients [1] . We also found that LPS induced the dephosphorylation of radixin and the disruption of the binding between Mrp2 and radixin, which decreased the expression of Mrp2 on the apical membrane, thereby leading to the internalization of Mrp2 in rat liver [11] . We have demonstrated that LPS-induced oxidative stress is a trigger factor that commonly regulates Mrp2/MRP2 internalization in both rat and human livers [36] . Observations strongly suggest that the phosphorylation status of Thr564 radixin might be a key factor in cholestatic jaundice, which is accompanied by MRP2/Mrp2 internalization in both human and rat livers. In contrast, p-radixin is phosphorylated after replenishment of GSH in a PKA-dependent manner and the association between Mrp2 and p-radixin was restored, which returned Mrp2 localization to its normal status. *1: We have reported that t-BHP-induced GSH decrease causes Ca 2+ elevation and NO release and finally leads to PKC activation in IRHCs [3] . *2: dibutyryl cAMP, stimulates sorting of Mrp2 from cytosol to the apical membrane in IRHCs [31] . Our previous reports also show that decreased cAMP content induced by t-BHP was significantly increased during the replenishment of GSH content in IRHCs and recovery of the Mrp2-index after GSH replenishment was significantly inhibited in the presence of a PKA inhibitor [5] .
In conclusion, we found that the balance of activation of PKA and PKC, mediated by variations in intercellular GSH, determines the phosphorylation status of radixin, which subsequently results in redox-sensitive canalicular Mrp2 localization.
